Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Cash Flow Statement
Cash Flow Statement
Caliway Biopharmaceuticals Co Ltd
| Dec-2022 | Jun-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(286)
|
(429)
|
(488)
|
(706)
|
(622)
|
(760)
|
(589)
|
(546)
|
(618)
|
(488)
|
|
| Depreciation & Amortization |
25
|
27
|
28
|
35
|
28
|
36
|
30
|
30
|
31
|
31
|
|
| Stock-Based Compensation |
19
|
0
|
23
|
4
|
8
|
27
|
49
|
78
|
156
|
0
|
|
| Other Non-Cash Items |
15
|
14
|
6
|
6
|
(7)
|
16
|
(9)
|
(20)
|
28
|
(73)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
1
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
4
|
31
|
82
|
51
|
38
|
46
|
56
|
102
|
125
|
|
| Cash from Operating Activities |
(243)
N/A
|
(384)
-58%
|
(424)
-10%
|
(584)
-38%
|
(550)
+6%
|
(669)
-22%
|
(522)
+22%
|
(480)
+8%
|
(458)
+5%
|
(407)
+11%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(14)
|
(10)
|
(10)
|
(11)
|
(16)
|
(19)
|
(11)
|
(14)
|
(10)
|
(13)
|
|
| Other Items |
(456)
|
(57)
|
167
|
167
|
(309)
|
(287)
|
(2 478)
|
35
|
(1 137)
|
(5 610)
|
|
| Cash from Investing Activities |
(471)
N/A
|
(67)
+86%
|
157
N/A
|
156
-1%
|
(326)
N/A
|
(307)
+6%
|
(2 489)
-712%
|
22
N/A
|
(1 147)
N/A
|
(5 624)
-390%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
784
|
9
|
3 042
|
3 043
|
3 043
|
9 521
|
6 499
|
6 504
|
6 538
|
40
|
|
| Net Issuance of Debt |
(13)
|
(8)
|
(8)
|
(10)
|
(8)
|
(11)
|
(9)
|
(9)
|
(9)
|
(9)
|
|
| Cash from Financing Activities |
772
N/A
|
1
-100%
|
3 034
+324 352%
|
3 033
0%
|
3 035
+0%
|
9 511
+213%
|
6 491
-32%
|
6 496
+0%
|
6 529
+1%
|
32
-100%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
2
|
0
|
0
|
0
|
1
|
1
|
(0)
|
0
|
(1)
|
(26)
|
|
| Net Change in Cash |
60
N/A
|
(451)
N/A
|
2 767
N/A
|
2 605
-6%
|
2 160
-17%
|
8 536
+295%
|
3 479
-59%
|
6 038
+74%
|
4 924
-18%
|
(6 025)
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(257)
N/A
|
(395)
-54%
|
(434)
-10%
|
(595)
-37%
|
(566)
+5%
|
(688)
-22%
|
(533)
+22%
|
(494)
+7%
|
(468)
+5%
|
(420)
+10%
|
|